Dr. Grapski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1915 White Avenue
Knoxville, TN 37916Phone+1 865-541-1720Fax+1 865-541-2640
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
UMass Chan Medical SchoolResidency, Internal Medicine, 1978 - 1981
Loyola University Chicago Stritch School of MedicineClass of 1978
Certifications & Licensure
TN State Medical License 1997 - 2021
Clinical Trials
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- 7 citationsA Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast CancerDenise A. Yardley, N. W. Peacock, Natalie R. Dickson, Melissa B. White, Elizabeth R. Vazquez
Clinical Breast Cancer. 2010-06-01 - 38 citationsIrinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research NetworkDavid R. Spigel, John D. Hainsworth, L. Simons, Christina Meng, Howard A. Burris
Journal of Thoracic Oncology. 2007-09-01 - 5 citationsLate postsplenectomy recurrence of thrombotic thrombocytopenic purpura responding to removal of accessory spleen.Lilia Talarico, Richard Grapski, Charles K. Lutz, Lewis R. Weintraub
The American Journal of Medicine. 1987-04-01
Press Mentions
Tennessee's Lung Cancer Rates Among Highest, but New Treatments, Screenings Offer HopeApril 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
